CoverageForm 410-K10-Q8-K13D13G13F

Stehman-Breen Catherine

CIK 0001702233
Director

Filings

14

Latest May 29, 2026

Issuers covered

3

Showing

14 of 14

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Stehman-Breen Catherine. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Stehman-Breen Catherine has filed

TickerIssuerFilingsLast filed
GBIOGeneration Bio Co.5Feb 9, 2026
TNYATenaya Therapeutics, Inc.5May 29, 2026
DYNDyne Therapeutics, Inc.4Jun 3, 2025

All filings

14 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue